Human C-Peptide Trifluoroacetate

Supplier: BACHEM AMERICAS INC

4009494.0500 4009494.1000
H-2470.0500BAEA 529.25 CAD
H-2470.0500BA H-2470.1000BA
Human C-Peptide Trifluoroacetate
Proteins and Peptides

Synthesized prosequences from insulin.


The measurement of the C-peptide under standardized conditions provides a sensitive, well accepted, and clinically validated assessment of β-cell function. The C-peptide measurement is the most suitable primary outcome for clinical trials of therapies aimed at preserving or improving endogenous insulin secretion in type 1 diabetes patients. C-peptide also shows hormonal activity. Clinical studies demonstrated that C-peptide administration in type 1 diabetes patients, who lack the peptide, alleviates the diabetes-induced renal and nerve dysfunctions.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR